2m 2m 2m 2m 2m 2m 2m
ALZAMEND (ALZN)
NASDAQ
$1.15+$0.01 (+1.23%)
Price as of Jun 03, 2026 7:52 PM EDT- $4.5MMarket Cap
- -70.23%1-Year Change
- BiotechnologyIndustry
ALZAMEND (ALZN)
$1.15+$0.01 (+1.23%)
ALZN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.14 | ||
Change | -$0.03 (-2.56%) | ||
Open | $1.16 | ||
High | $1.16 | ||
Low | $1.12 | ||
Previous Close | $1.17 | ||
Volume | 45,986 | ||
30-Day Average Volume | 66,720 | ||
1-Week Change | -0.87% | ||
1-Month Change | 1.79% | ||
1-Year Change | -70.23% | ||
3-Year Change | -99.88% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 3.8M | ||
Total Assets | $4.0M | ||
Market Cap | $4.5M | ||
Enterprise Value | $1.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.2M | ||
Free Cash Flow | -$1.7M | ||
EBIT | -$2.2M | ||
EBITDA | -$2.2M | ||
Net Working Capital | $1.8M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 9 | ||
Last Split Date | 05/12/2025 | ||